Biotech · Private company
Pharmacosmos A/S
Track this companyFree. Adds Pharmacosmos A/S to your Dealase workspace and tells you when its record changes.
Clinical trials103 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Ferric carboxymaltosePhase 3 · Iron Deficiency AnaemiaClinicalTrials.gov · fetched Nov 12, 2026
- Ferric DerisomaltosePhase 3 · Chronic Heart FailureClinicalTrials.gov · fetched Nov 12, 2026
- Ferric DerisomaltosePhase 3 · Iron Deficiency, Anaemia in ChildrenClinicalTrials.gov · fetched Nov 12, 2026
- Iron isomaltoside/ferric derisomaltosePhase 3 · Iron Deficiency AnaemiaClinicalTrials.gov · fetched Nov 12, 2026
- Iron isomaltoside/ferric derisomaltosePhase 3 · Iron Deficiency AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- Iron sucrosePhase 3 · Iron Deficiency AnaemiaClinicalTrials.gov · fetched Nov 12, 2026
- TrilaciclibPhase 3 · Limited Stage Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung CancerPHASE3 · RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07473128 · fetched Nov 12, 2026
- Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart FailurePHASE3 · RECRUITING · started May 1, 2025ClinicalTrials.gov NCT06929806 · fetched Nov 12, 2026
- Preoperative Monoferric for Abdominal SurgeryPHASE4 · COMPLETED · started Apr 18, 2023ClinicalTrials.gov NCT05258825 · fetched Nov 12, 2026
- Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency AnemiaPHASE3 · RECRUITING · started Nov 28, 2022ClinicalTrials.gov NCT05179226 · fetched Nov 12, 2026
- Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)PHASE2_PHASE3 · COMPLETED · started Nov 26, 2021ClinicalTrials.gov NCT04945707 · fetched Nov 12, 2026
- Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency AnaemiaPHASE3 · COMPLETED · started Oct 30, 2017ClinicalTrials.gov NCT03237065 · fetched Nov 12, 2026
- Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency AnaemiaPHASE3 · COMPLETED · started Oct 24, 2017ClinicalTrials.gov NCT03238911 · fetched Nov 12, 2026
- An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®)PHASE3 · COMPLETED · started Jan 9, 2017ClinicalTrials.gov NCT02962648 · fetched Nov 12, 2026
- Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney DiseasePHASE3 · COMPLETED · started Nov 29, 2016ClinicalTrials.gov NCT02940860 · fetched Nov 12, 2026
- Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)PHASE3 · COMPLETED · started Nov 8, 2016ClinicalTrials.gov NCT02940886 · fetched Nov 12, 2026